| Mrs Faith Miller Whalen, MD | |
|
90 Ridgewood Dr, Bangor, ME 04401-2652 | |
| (207) 942-0669 | |
| (207) 947-3143 |
| Full Name | Mrs Faith Miller Whalen |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 15 Years |
| Location | 90 Ridgewood Dr, Bangor, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124256029 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD19826 (Maine) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Penobscot Valley Dermatology Pa | 7315092541 | 8 |
News Archive
Endo Pharmaceuticals today reported financial results for the first quarter 2010.
Brazilian researchers believe they have identified in patients treated at the University Hospital (HU) in Aracaju, state of Sergipe, a new species of parasite that can cause a disease similar to visceral leishmaniasis but is resistant to the treatments currently available.
Oragenics, Inc., today announced that its board of directors has approved a 1-for-20 reverse stock split and that the Financial Industry Regulatory Authority has cleared the reverse stock split to become effective with the opening of trading on Tuesday, September 28, 2010.
This advancement has the potential to significantly speed the development of new, improved therapies for diffuse large B cell lymphoma (DLBCL), the most common type of human B cell lymphoma. Human B cell lymphomas cause 85 percent of non-Hodgkin's lymphomas, the sixth leading cause of cancer deaths in the United States.
University of Michigan researchers will use a new $1.6 million federal grant to probe potential social and environmental links to autism, collecting location-specific information from tens of thousands of affected individuals and their families nationwide.
› Verified 7 days ago
| Entity Name | Penobscot Valley Dermatology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952536880 PECOS PAC ID: 7315092541 Enrollment ID: O20090911000198 |
News Archive
Endo Pharmaceuticals today reported financial results for the first quarter 2010.
Brazilian researchers believe they have identified in patients treated at the University Hospital (HU) in Aracaju, state of Sergipe, a new species of parasite that can cause a disease similar to visceral leishmaniasis but is resistant to the treatments currently available.
Oragenics, Inc., today announced that its board of directors has approved a 1-for-20 reverse stock split and that the Financial Industry Regulatory Authority has cleared the reverse stock split to become effective with the opening of trading on Tuesday, September 28, 2010.
This advancement has the potential to significantly speed the development of new, improved therapies for diffuse large B cell lymphoma (DLBCL), the most common type of human B cell lymphoma. Human B cell lymphomas cause 85 percent of non-Hodgkin's lymphomas, the sixth leading cause of cancer deaths in the United States.
University of Michigan researchers will use a new $1.6 million federal grant to probe potential social and environmental links to autism, collecting location-specific information from tens of thousands of affected individuals and their families nationwide.
› Verified 7 days ago
| Entity Name | Northern Maine Skin Cancer Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063198554 PECOS PAC ID: 3678934742 Enrollment ID: O20230804003298 |
News Archive
Endo Pharmaceuticals today reported financial results for the first quarter 2010.
Brazilian researchers believe they have identified in patients treated at the University Hospital (HU) in Aracaju, state of Sergipe, a new species of parasite that can cause a disease similar to visceral leishmaniasis but is resistant to the treatments currently available.
Oragenics, Inc., today announced that its board of directors has approved a 1-for-20 reverse stock split and that the Financial Industry Regulatory Authority has cleared the reverse stock split to become effective with the opening of trading on Tuesday, September 28, 2010.
This advancement has the potential to significantly speed the development of new, improved therapies for diffuse large B cell lymphoma (DLBCL), the most common type of human B cell lymphoma. Human B cell lymphomas cause 85 percent of non-Hodgkin's lymphomas, the sixth leading cause of cancer deaths in the United States.
University of Michigan researchers will use a new $1.6 million federal grant to probe potential social and environmental links to autism, collecting location-specific information from tens of thousands of affected individuals and their families nationwide.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Faith Miller Whalen, MD 90 Ridgewood Dr, Bangor, ME 04401-2652 Ph: (207) 942-0669 | Mrs Faith Miller Whalen, MD 90 Ridgewood Dr, Bangor, ME 04401-2652 Ph: (207) 942-0669 |
News Archive
Endo Pharmaceuticals today reported financial results for the first quarter 2010.
Brazilian researchers believe they have identified in patients treated at the University Hospital (HU) in Aracaju, state of Sergipe, a new species of parasite that can cause a disease similar to visceral leishmaniasis but is resistant to the treatments currently available.
Oragenics, Inc., today announced that its board of directors has approved a 1-for-20 reverse stock split and that the Financial Industry Regulatory Authority has cleared the reverse stock split to become effective with the opening of trading on Tuesday, September 28, 2010.
This advancement has the potential to significantly speed the development of new, improved therapies for diffuse large B cell lymphoma (DLBCL), the most common type of human B cell lymphoma. Human B cell lymphomas cause 85 percent of non-Hodgkin's lymphomas, the sixth leading cause of cancer deaths in the United States.
University of Michigan researchers will use a new $1.6 million federal grant to probe potential social and environmental links to autism, collecting location-specific information from tens of thousands of affected individuals and their families nationwide.
› Verified 7 days ago
Dr. Jeffrey Dean Pittis, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 90 Ridgewood Dr, Bangor, ME 04401 Phone: 207-942-0669 Fax: 207-947-3143 | |
Dr. Orville Albert Hartford, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 90 Ridgewood Dr, Bangor, ME 04401 Phone: 207-942-0669 Fax: 207-947-3143 | |
Robert Wynne Haeberlein Jr., MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 700 Mount Hope Avenue Suite 601, Bangor, ME 04401 Phone: 207-942-4653 Fax: 207-990-4795 | |
Dr. Jaymie Fe Potenciano Panuncialman, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 35 State Hospital Dr, Bangor, ME 04401 Phone: 207-561-3600 | |
William F Gallagher, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1012 Union St, Bangor, ME 04401 Phone: 207-945-5247 Fax: 207-990-1248 | |
Mrs. Samantha Helene Mitchell, FNP-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 90 Ridgewood Dr, Bangor, ME 04401 Phone: 207-942-0669 Fax: 207-947-3143 |